Free Trial
OTCMKTS:GENSF

Genus (GENSF) Stock Price, News & Analysis

Genus logo
$21.77 0.00 (0.00%)
As of 05/2/2025

About Genus Stock (OTCMKTS:GENSF)

Key Stats

Today's Range
$21.77
$21.77
50-Day Range
$21.00
$25.51
52-Week Range
$20.51
$25.51
Volume
N/A
Average Volume
600 shs
Market Capitalization
N/A
P/E Ratio
45.73
Dividend Yield
0.76%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Genus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

GENSF MarketRank™: 

Genus scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Genus.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genus is 45.73, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.98.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genus is 45.73, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.81.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Genus has a short interest ratio ("days to cover") of 28, which indicates bearish sentiment.
  • Change versus previous month

  • Dividend Yield

    Genus pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genus does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Genus is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Genus' dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Genus has a short interest ratio ("days to cover") of 28, which indicates bearish sentiment.
  • Change versus previous month

  • News Sentiment

    Genus has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Genus this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Genus insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 29.70% of the stock of Genus is held by institutions.

  • Read more about Genus' insider trading history.
Receive GENSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

GENSF Stock News Headlines

Genus plc Updates Total Voting Rights Information
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.
Genus plc (GENSF) Q2 2025 Earnings Call Transcript
See More Headlines

GENSF Stock Analysis - Frequently Asked Questions

Genus' stock was trading at $21.0050 at the start of the year. Since then, GENSF stock has increased by 3.6% and is now trading at $21.7680.
View the best growth stocks for 2025 here
.

Shares of GENSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:GENSF
CIK
N/A
Fax
N/A
Employees
3,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
45.73
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:GENSF) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners